CLN-081

· Cullinan Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CLN-081, covering 2025-03-13 to 2025-03-13. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1/2 Trial of CLN-081 in Patients With Non-Small Cell Lung Cancer [Phase 1, Phase 2]